PT Metro Healthcare Indonesia Tbk reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was IDR 112,665.48 million compared to IDR 146,263.38 million a year ago. Net loss was IDR 51,741.15 million compared to net income of IDR 15,707.79 million a year ago.

Basic loss per share from continuing operations was IDR 1.556 compared to basic earnings per share from continuing operations of IDR 0.472 a year ago.